Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

How can we minimise the use of regular oral corticosteroids in asthma?

Bourdin A, Adcock I, Berger P, Bonniaud P, Chanson P, Chenivesse C, de Blic J, Deschildre A, Devillier P, Devouassoux G, Didier A, Garcia G, Magnan A, Martinat Y, Perez T, Roche N, Taillé C, Val P, Chanez P.

Eur Respir Rev. 2020 Feb 5;29(155). pii: 190085. doi: 10.1183/16000617.0085-2019. Print 2020 Mar 31. Review. Erratum in: Eur Respir Rev. 2020 Feb 12;29(155):.

2.

Eroded enamel rehardening using two intraoral appliances designs in different times of salivary exposure.

Mendonça FL, Jordão MC, Val PP, de Alencar CR, Bassoto MA, Honório HM, Magalhães AC, Buzalaf MA, da Silva TC, Rios D.

J Clin Exp Dent. 2019 Dec 1;11(12):e1127-e1132. doi: 10.4317/jced.56222. eCollection 2019 Dec.

3.

EZH2 cooperates with E2F1 to stimulate expression of genes involved in adrenocortical carcinoma aggressiveness.

Tabbal H, Septier A, Mathieu M, Drelon C, Rodriguez S, Djari C, Batisse-Lignier M, Tauveron I, Pointud JC, Sahut-Barnola I, Ragazzon B, Assié G, Bertherat J, Lefrançois-Martinez AM, Martinez A, Val P.

Br J Cancer. 2019 Aug;121(5):384-394. doi: 10.1038/s41416-019-0538-y. Epub 2019 Jul 31.

PMID:
31363169
4.

Hormonal and spatial control of SUMOylation in the human and mouse adrenal cortex.

Dumontet T, Sahut-Barnola I, Dufour D, Lefrançois-Martinez AM, Berthon A, Montanier N, Ragazzon B, Djari C, Pointud JC, Roucher-Boulez F, Batisse-Lignier M, Tauveron I, Bertherat J, Val P, Martinez A.

FASEB J. 2019 Sep;33(9):10218-10230. doi: 10.1096/fj.201900557R. Epub 2019 Jun 17.

PMID:
31208233
5.

A ZNRF3-dependent Wnt/β-catenin signaling gradient is required for adrenal homeostasis.

Basham KJ, Rodriguez S, Turcu AF, Lerario AM, Logan CY, Rysztak MR, Gomez-Sanchez CE, Breault DT, Koo BK, Clevers H, Nusse R, Val P, Hammer GD.

Genes Dev. 2019 Feb 1;33(3-4):209-220. doi: 10.1101/gad.317412.118. Epub 2019 Jan 28.

6.

Steroidogenic differentiation and PKA signaling are programmed by histone methyltransferase EZH2 in the adrenal cortex.

Mathieu M, Drelon C, Rodriguez S, Tabbal H, Septier A, Damon-Soubeyrand C, Dumontet T, Berthon A, Sahut-Barnola I, Djari C, Batisse-Lignier M, Pointud JC, Richard D, Kerdivel G, Calméjane MA, Boeva V, Tauveron I, Lefrançois-Martinez AM, Martinez A, Val P.

Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):E12265-E12274. doi: 10.1073/pnas.1809185115. Epub 2018 Dec 12.

7.

Synthesis of Polysubstituted Tetrahydropyrans by Stereoselective Hydroalkoxylation of Silyl Alkenols: En Route to Tetrahydropyranyl Marine Analogues.

Díez-Poza C, Val P, Pulido FJ, Barbero A.

Mar Drugs. 2018 Nov 1;16(11). pii: E421. doi: 10.3390/md16110421.

8.

Effect of palm oil alone or associated to stannous solution on enamel erosive-abrasive wear: A randomized in situ/ex vivo study.

Ionta FQ, Alencar CRB, Santos NMD, Bergantin BTP, Val PP, Honório HM, Oliveira TM, Rios D.

Arch Oral Biol. 2018 Nov;95:68-73. doi: 10.1016/j.archoralbio.2018.07.013. Epub 2018 Jul 18.

PMID:
30064032
9.

Retraction Note: Liver X receptors constrain tumor development and metastasis dissemination in PTEN-deficient prostate cancer.

Alioui A, Dufour J, Leoni V, Loregger A, Moeton M, Iuliano L, Zerbinati C, Septier A, Val P, Fouache A, Russo V, Volle DH, Lobaccaro JA, Zelcer N, Baron S.

Nat Commun. 2018 Jul 4;9(1):2660. doi: 10.1038/s41467-018-04653-3.

10.

Adrenocortical development: Lessons from mouse models.

Dumontet T, Sahut-Barnola I, Septier A, Montanier N, Plotton I, Roucher-Boulez F, Ducros V, Lefrançois-Martinez AM, Pointud JC, Zubair M, Morohashi KI, Breault DT, Val P, Martinez A.

Ann Endocrinol (Paris). 2018 Jun;79(3):95-97. doi: 10.1016/j.ando.2018.03.014. Epub 2018 Apr 16.

PMID:
29673697
11.

PKA signaling drives reticularis differentiation and sexually dimorphic adrenal cortex renewal.

Dumontet T, Sahut-Barnola I, Septier A, Montanier N, Plotton I, Roucher-Boulez F, Ducros V, Lefrançois-Martinez AM, Pointud JC, Zubair M, Morohashi KI, Breault DT, Val P, Martinez A.

JCI Insight. 2018 Jan 25;3(2). pii: 98394. doi: 10.1172/jci.insight.98394. eCollection 2018 Jan 25.

12.

Effect of vegetable oils applied over acquired enamel pellicle on initial erosion.

Ionta FQ, Alencar CRB, Val PP, Boteon AP, Jordão MC, Honório HM, Buzalaf MAR, Rios D.

J Appl Oral Sci. 2017 Jul-Aug;25(4):420-426. doi: 10.1590/1678-7757-2016-0436.

13.

Liver X receptors constrain tumor development and metastasis dissemination in PTEN-deficient prostate cancer.

Alioui A, Dufour J, Leoni V, Loregger A, Moeton M, Iuliano L, Zerbinati C, Septier A, Val P, Fouache A, Russo V, Volle DH, Lobaccaro JA, Zelcer N, Baron S.

Nat Commun. 2017 Sep 5;8(1):445. doi: 10.1038/s41467-017-00508-5. Retraction in: Nat Commun. 2018 Jul 04;9(1):2660.

14.

P53/Rb inhibition induces metastatic adrenocortical carcinomas in a preclinical transgenic model.

Batisse-Lignier M, Sahut-Barnola I, Tissier F, Dumontet T, Mathieu M, Drelon C, Pointud JC, Damon-Soubeyrand C, Marceau G, Kemeny JL, Bertherat J, Tauveron I, Val P, Martinez A, Lefrançois-Martinez AM.

Oncogene. 2017 Aug;36(31):4445-4456. doi: 10.1038/onc.2017.54. Epub 2017 Apr 3.

PMID:
28368424
15.

PKA inhibits WNT signalling in adrenal cortex zonation and prevents malignant tumour development.

Drelon C, Berthon A, Sahut-Barnola I, Mathieu M, Dumontet T, Rodriguez S, Batisse-Lignier M, Tabbal H, Tauveron I, Lefrançois-Martinez AM, Pointud JC, Gomez-Sanchez CE, Vainio S, Shan J, Sacco S, Schedl A, Stratakis CA, Martinez A, Val P.

Nat Commun. 2016 Sep 14;7:12751. doi: 10.1038/ncomms12751.

16.

Mouse Models Recapitulating Human Adrenocortical Tumors: What Is Lacking?

Leccia F, Batisse-Lignier M, Sahut-Barnola I, Val P, Lefrançois-Martinez AM, Martinez A.

Front Endocrinol (Lausanne). 2016 Jul 15;7:93. doi: 10.3389/fendo.2016.00093. eCollection 2016. Review.

17.

Editorial: Adrenal Cortex: From Physiology to Disease.

Val P, Martinez A.

Front Endocrinol (Lausanne). 2016 Jun 1;7:51. doi: 10.3389/fendo.2016.00051. eCollection 2016. No abstract available.

18.

EZH2 is overexpressed in adrenocortical carcinoma and is associated with disease progression.

Drelon C, Berthon A, Mathieu M, Ragazzon B, Kuick R, Tabbal H, Septier A, Rodriguez S, Batisse-Lignier M, Sahut-Barnola I, Dumontet T, Pointud JC, Lefrançois-Martinez AM, Baron S, Giordano TJ, Bertherat J, Martinez A, Val P.

Hum Mol Genet. 2016 Jul 1;25(13):2789-2800. Epub 2016 May 5.

19.

Pregnancy, Primary Aldosteronism, and Somatic CTNNB1 Mutations.

Berthon A, Drelon C, Val P.

N Engl J Med. 2016 Apr 14;374(15):1493-4. doi: 10.1056/NEJMc1514508. No abstract available.

PMID:
27074082
20.

Combined transcriptome studies identify AFF3 as a mediator of the oncogenic effects of β-catenin in adrenocortical carcinoma.

Lefèvre L, Omeiri H, Drougat L, Hantel C, Giraud M, Val P, Rodriguez S, Perlemoine K, Blugeon C, Beuschlein F, de Reyniès A, Rizk-Rabin M, Bertherat J, Ragazzon B.

Oncogenesis. 2015 Jul 27;4:e161. doi: 10.1038/oncsis.2015.20.

21.

Aldose reductases influence prostaglandin F2α levels and adipocyte differentiation in male mouse and human species.

Pastel E, Pointud JC, Loubeau G, Dani C, Slim K, Martin G, Volat F, Sahut-Barnola I, Val P, Martinez A, Lefrançois-Martinez AM.

Endocrinology. 2015 May;156(5):1671-84. doi: 10.1210/en.2014-1750. Epub 2015 Mar 2.

PMID:
25730106
22.

Adrenal cortex tissue homeostasis and zonation: A WNT perspective.

Drelon C, Berthon A, Mathieu M, Martinez A, Val P.

Mol Cell Endocrinol. 2015 Jun 15;408:156-64. doi: 10.1016/j.mce.2014.12.014. Epub 2014 Dec 24. Review.

PMID:
25542843
23.

mTOR pathway is activated by PKA in adrenocortical cells and participates in vivo to apoptosis resistance in primary pigmented nodular adrenocortical disease (PPNAD).

de Joussineau C, Sahut-Barnola I, Tissier F, Dumontet T, Drelon C, Batisse-Lignier M, Tauveron I, Pointud JC, Lefrançois-Martinez AM, Stratakis CA, Bertherat J, Val P, Martinez A.

Hum Mol Genet. 2014 Oct 15;23(20):5418-28. doi: 10.1093/hmg/ddu265. Epub 2014 May 27.

24.

WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production.

Berthon A, Drelon C, Ragazzon B, Boulkroun S, Tissier F, Amar L, Samson-Couterie B, Zennaro MC, Plouin PF, Skah S, Plateroti M, Lefèbvre H, Sahut-Barnola I, Batisse-Lignier M, Assié G, Lefrançois-Martinez AM, Bertherat J, Martinez A, Val P.

Hum Mol Genet. 2014 Feb 15;23(4):889-905. doi: 10.1093/hmg/ddt484. Epub 2013 Oct 1.

PMID:
24087794
25.

Liver x receptors protect from development of prostatic intra-epithelial neoplasia in mice.

Pommier AJ, Dufour J, Alves G, Viennois E, De Boussac H, Trousson A, Volle DH, Caira F, Val P, Arnaud P, Lobaccaro JM, Baron S.

PLoS Genet. 2013 May;9(5):e1003483. doi: 10.1371/journal.pgen.1003483. Epub 2013 May 9.

26.

Adrenocortical cancer and IGF2: is the game over or our experimental models limited?

Drelon C, Berthon A, Val P.

J Clin Endocrinol Metab. 2013 Feb;98(2):505-7. doi: 10.1210/jc.2012-3310. Epub 2013 Jan 7. No abstract available.

PMID:
23295462
27.

In vivo evidence for the crucial role of SF1 in steroid-producing cells of the testis, ovary and adrenal gland.

Buaas FW, Gardiner JR, Clayton S, Val P, Swain A.

Development. 2012 Dec;139(24):4561-70. doi: 10.1242/dev.087247. Epub 2012 Nov 7.

28.

Analysis of the role of Igf2 in adrenal tumour development in transgenic mouse models.

Drelon C, Berthon A, Ragazzon B, Tissier F, Bandiera R, Sahut-Barnola I, de Joussineau C, Batisse-Lignier M, Lefrançois-Martinez AM, Bertherat J, Martinez A, Val P.

PLoS One. 2012;7(8):e44171. doi: 10.1371/journal.pone.0044171. Epub 2012 Aug 28.

29.

The cAMP pathway and the control of adrenocortical development and growth.

de Joussineau C, Sahut-Barnola I, Levy I, Saloustros E, Val P, Stratakis CA, Martinez A.

Mol Cell Endocrinol. 2012 Mar 31;351(1):28-36. doi: 10.1016/j.mce.2011.10.006. Epub 2011 Oct 15. Review.

30.

Wnt/β-catenin signalling in adrenal physiology and tumour development.

Berthon A, Martinez A, Bertherat J, Val P.

Mol Cell Endocrinol. 2012 Mar 31;351(1):87-95. doi: 10.1016/j.mce.2011.09.009. Epub 2011 Sep 10. Review.

PMID:
21930188
31.

Transcriptional control of adrenal steroidogenesis: novel connection between Janus kinase (JAK) 2 protein and protein kinase A (PKA) through stabilization of cAMP response element-binding protein (CREB) transcription factor.

Lefrancois-Martinez AM, Blondet-Trichard A, Binart N, Val P, Chambon C, Sahut-Barnola I, Pointud JC, Martinez A.

J Biol Chem. 2011 Sep 23;286(38):32976-85. doi: 10.1074/jbc.M111.218016. Epub 2011 Aug 1.

32.

Cushing's syndrome and fetal features resurgence in adrenal cortex-specific Prkar1a knockout mice.

Sahut-Barnola I, de Joussineau C, Val P, Lambert-Langlais S, Damon C, Lefrançois-Martinez AM, Pointud JC, Marceau G, Sapin V, Tissier F, Ragazzon B, Bertherat J, Kirschner LS, Stratakis CA, Martinez A.

PLoS Genet. 2010 Jun 10;6(6):e1000980. doi: 10.1371/journal.pgen.1000980.

33.

Constitutive beta-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development.

Berthon A, Sahut-Barnola I, Lambert-Langlais S, de Joussineau C, Damon-Soubeyrand C, Louiset E, Taketo MM, Tissier F, Bertherat J, Lefrançois-Martinez AM, Martinez A, Val P.

Hum Mol Genet. 2010 Apr 15;19(8):1561-76. doi: 10.1093/hmg/ddq029. Epub 2010 Jan 27.

PMID:
20106872
34.

Gene dosage effects and transcriptional regulation of early mammalian adrenal cortex development.

Val P, Swain A.

Mol Cell Endocrinol. 2010 Jul 8;323(1):105-14. doi: 10.1016/j.mce.2009.12.010. Epub 2009 Dec 16. Review. No abstract available.

PMID:
20025938
35.

Aldo keto reductase 1B7 and prostaglandin F2alpha are regulators of adrenal endocrine functions.

Lambert-Langlais S, Pointud JC, Lefrançois-Martinez AM, Volat F, Manin M, Coudoré F, Val P, Sahut-Barnola I, Ragazzon B, Louiset E, Delarue C, Lefebvre H, Urade Y, Martinez A.

PLoS One. 2009 Oct 7;4(10):e7309. doi: 10.1371/journal.pone.0007309.

36.

The transcription co-factor CITED2 functions during sex determination and early gonad development.

Buaas FW, Val P, Swain A.

Hum Mol Genet. 2009 Aug 15;18(16):2989-3001. doi: 10.1093/hmg/ddp237. Epub 2009 May 20.

PMID:
19457926
37.

Mouse model for bilateral adrenal hyperplasia.

Sahut-Barnola I, De Joussineau C, Val P, Lambert-Langlais S, Lefrançois-Martinez AM, Pointud JC, Marceau G, Sapin V, Ragazzon B, Bertherat J, Kirschner LS, Stratakis CA, Martinez A.

Ann Endocrinol (Paris). 2009 Jun;70(3):194. doi: 10.1016/j.ando.2009.02.004. Epub 2009 Mar 14. No abstract available.

38.

A transgenic mouse line with specific Cre recombinase expression in the adrenal cortex.

Lambert-Langlais S, Val P, Guyot S, Ragazzon B, Sahut-Barnola I, De Haze A, Lefrançois-Martinez AM, Martinez A.

Mol Cell Endocrinol. 2009 Mar 5;300(1-2):197-204. doi: 10.1016/j.mce.2008.10.045. Epub 2008 Nov 8.

PMID:
19041690
39.

Adrenal development is initiated by Cited2 and Wt1 through modulation of Sf-1 dosage.

Val P, Martinez-Barbera JP, Swain A.

Development. 2007 Jun;134(12):2349-58.

40.

Identification of a novel population of adrenal-like cells in the mammalian testis.

Val P, Jeays-Ward K, Swain A.

Dev Biol. 2006 Nov 1;299(1):250-6. Epub 2006 Jul 31.

41.

Mechanisms of Disease: normal and abnormal gonadal development and sex determination in mammals.

Val P, Swain A.

Nat Clin Pract Urol. 2005 Dec;2(12):616-27. Review.

PMID:
16474549
42.

Adrenocorticotropin-dependent changes in SF-1/DAX-1 ratio influence steroidogenic genes expression in a novel model of glucocorticoid-producing adrenocortical cell lines derived from targeted tumorigenesis.

Ragazzon B, Lefrançois-Martinez AM, Val P, Sahut-Barnola I, Tournaire C, Chambon C, Gachancard-Bouya JL, Begue RJ, Veyssière G, Martinez A.

Endocrinology. 2006 Apr;147(4):1805-18. Epub 2006 Jan 26.

PMID:
16439455
43.

ACTH and PRL sensitivity of highly differentiated cell lines obtained by adrenocortical targeted oncogenesis.

Ragazzon B, Lefrançois-Martinez AM, Val P, Tournaire C, Berger M, Gachancard-Bouya JL, Bègue RJ, Veyssière G, Martinez A.

Endocr Res. 2004 Nov;30(4):945-50.

PMID:
15666850
44.

Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumors.

Lefrançois-Martinez AM, Bertherat J, Val P, Tournaire C, Gallo-Payet N, Hyndman D, Veyssière G, Bertagna X, Jean C, Martinez A.

J Clin Endocrinol Metab. 2004 Jun;89(6):3010-9.

PMID:
15181092
45.

Regulation of the aldo-keto reductase gene akr1b7 by the nuclear oxysterol receptor LXRalpha (liver X receptor-alpha) in the mouse intestine: putative role of LXRs in lipid detoxification processes.

Volle DH, Repa JJ, Mazur A, Cummins CL, Val P, Henry-Berger J, Caira F, Veyssiere G, Mangelsdorf DJ, Lobaccaro JM.

Mol Endocrinol. 2004 Apr;18(4):888-98. Epub 2004 Jan 22.

PMID:
14739254
46.

Adrenocorticotropin/3',5'-cyclic AMP-mediated transcription of the scavenger akr1-b7 gene in adrenocortical cells is dependent on three functionally distinct steroidogenic factor-1-responsive elements.

Val P, Aigueperse C, Ragazzon B, Veyssière G, Lefrançois-Martinez AM, Martinez A.

Endocrinology. 2004 Feb;145(2):508-18. Epub 2003 Nov 6.

PMID:
14605009
47.

SF-1 a key player in the development and differentiation of steroidogenic tissues.

Val P, Lefrançois-Martinez AM, Veyssière G, Martinez A.

Nucl Recept. 2003 Sep 18;1(1):8.

48.

Steroidogenic factor-1 controls the aldose reductase akr1b7 gene promoter in transgenic mice through an atypical binding site.

Martinez A, Val P, Sahut-Barnola I, Aigueperse C, Veyssière G, Lefrançois-Martinez AM.

Endocrinology. 2003 May;144(5):2111-20.

PMID:
12697720
49.

Role of three SF-1 binding sites in the expression of the mvdp/akr1-b7 isocaproaldehyde reductase in Y1 cells.

Val P, Aigueperse C, Lefrançois-Martinez AM, Jean C, Veyssière G, Martinez A.

Endocr Res. 2002 Nov;28(4):527-33. Review.

PMID:
12530658
50.

SF-1 controls the expression of the scavenger gene akr1b7: in vitro and in vivo approaches.

Martinez A, Val P, Jean C, Veyssière G, Lefrançois-Martinez AM.

Endocr Res. 2002 Nov;28(4):515-8. No abstract available.

PMID:
12530656

Supplemental Content

Support Center